Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Earning cash in an organized manner can enhance your financial health. Explore effective methods to streamline your income-earning activities.
19,213 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
BTIG raises its CrowdStrike price target to $621 from $499, signaling strong momentum in platform consolidation among...
Global markets sold off after leaders offered little concrete trade progress. Investors warn that day one of talks ma...
A growing number of retirees are reconsidering traditional withdrawal rules, choosing to front-load discretionary spe...
A suspected multichain exploit on THORChain prompted rapid emergency halts across several networks, challenging the p...
The White House announced that China will buy a minimum of $17 billion in U.S. agricultural goods each year through 2...
The Kiplinger Letter argues that most GDP growth celebrated in Washington isn’t driven by AI, a claim with sharp impl...
An experienced investment banker explains why pension funds stick with complex alternatives even when a simple 60/40 ...
Public safety workers can tap 401(k) and 457(b) plans at age 50 without the 10% early withdrawal penalty under a long...
Metropolis has surged to a $5 billion valuation after a 2025 funding round, transforming parking networks into a broa...
Mizuho ups UnitedHealth's price target to $440, citing easing medical loss ratio pressures and a turning Medicare Adv...
A new northwestern mutual 2025 study shows most Americans have no will, with Gen X and Baby Boomers lagging in estate...